Your session is about to expire
← Back to Search
APPS Intervention for Domestic Violence Prevention (APPS Trial)
N/A
Waitlist Available
Led By Garen J Wintemute, MD, MPH
Research Sponsored by University of California, Davis
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Adults with records of firearms ownership who have experienced a prohibiting event. Prohibiting events are based in Federal and California state law. Among others, they include criminal convictions for felonies and selected violent misdemeanors; emergency hospitalization for dangerousness associated with severe mental illness, as specified in statute; and status as respondent to a domestic violence restraining order.
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 3 years
Awards & highlights
No Placebo-Only Group
Summary
This trial looks at whether the California system that stops people who have legally purchased firearms but are now prohibited from owning them from owning them, reduces the risk of future violence among those people.
Who is the study for?
This trial is for adults in California who previously bought firearms legally but can't own them anymore due to certain events like felony convictions, violent misdemeanors, mental illness-related hospitalizations, or being under a domestic violence restraining order.
What is being tested?
The study is testing the impact of California's Armed and Prohibited Persons System (APPS), which aims to reduce future violence by preventing individuals with prohibiting events from owning firearms.
What are the potential side effects?
Since this trial evaluates a legal intervention rather than a medical one, it does not have side effects in the traditional sense. The focus is on societal outcomes such as reduced risk of violence.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I own a firearm and have had a legal issue that prohibits me from owning it.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 3 years
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 3 years
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Incidence of arrest for violent and firearm-related crimes
Secondary study objectives
Incidence of arrest for non-violent, non firearms-related crimes
Incidence of domestic violence restraining orders
Incidence of emergency mental health hospitalizations
Other study objectives
Community level rates of violence
Cost benefit analysis
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Group 1Experimental Treatment1 Intervention
APPS intervention will be implemented in Group 1 communities prior to implementation in Group 2 communities.
Group II: Group 2Active Control1 Intervention
APPS intervention will be implemented in Group 2 communities following implementation in Group 1 communities.
Find a Location
Who is running the clinical trial?
Stanford UniversityOTHER
2,474 Previous Clinical Trials
17,481,940 Total Patients Enrolled
Northeastern UniversityOTHER
98 Previous Clinical Trials
50,996 Total Patients Enrolled
University of California, DavisLead Sponsor
943 Previous Clinical Trials
4,735,688 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I own a firearm and have had a legal issue that prohibits me from owning it.Not applicable.
Research Study Groups:
This trial has the following groups:- Group 1: Group 2
- Group 2: Group 1
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Share this study with friends
Copy Link
Messenger